Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1201627015 | Aminocaproic acid 500mg (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1214604015 | Aminocaproic acid 500mg | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1458624014 | Aminocaproic acid 500mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478450018 | Aminocaproic acid 500mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3490193019 | Product containing aminocaproic acid 500 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3494020017 | Product containing aminocaproic acid 500 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501444017 | Aminocaproic acid 500 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3568713014 | Product containing only aminocaproic acid 500 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568714015 | Product containing only aminocaproic acid 500 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3676477012 | Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3676478019 | Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Is a | Product containing aminocaproic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has active ingredient | Aminocaproic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Is a | Product containing aminocaproic acid in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has active ingredient | Aminocaproic acid | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Aminocaproic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Aminocaproic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Is a | Product containing only aminocaproic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet | Plays role | Hemostatic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR